Table 3. Summary of previous studies from different regions about NDRD in diabetic patients.
Duration | Number of patients | DN | NDRD | NDRD + DN | Most common NDRD | |
---|---|---|---|---|---|---|
2011 Korea | 1988–2008 | 119 T2DM | 43 (36.1%) | 64 (53.8%) | 12 (10.1%) | MN |
2012 Malaysia | 2004–2008 | 110 T2DM | 69 (62.7%) | 20 (18.2%) | 21 (19.1%) | AIN |
2013 China | 2003–2010 | 216 T2DM | 14 (6.5%) | 179 (82.9%) | 23 (10.7%) | IgAN |
2013 China | 2003–2011 | 244 T2DM | 20 (8.2%) | 205 (84%) | 19 (7.8%) | IgAN |
2013 Korea | 2000–2011 | 110 T2DM | 41 (37.3%) | 59 (53.6%) | 10 (9.1%) | IgAN |
2013 USA | 2011 | 620 T2DM | 227 (37%) | 220 (36%) | 164 (27%) | FSGS |
2014 Croatia | 2004–2013 | 80 T2DM | 37 (46.25%) | 29 (36.25%) | 14 (17.5%) | MN |
2014 New Zealand | 2004–2006 | 93 T2DM | 30 (32%) | 17 (18%) | 46 (49%) | FSGS |
2016 China | 2000–2015 | 273 T2DM | 68 (24.9%) | 175 (64.1%) | 30 (11.0%) | MN |
Notes.
Values are expressed as frequencies and percentages (n(%)).
- NDRD
- non-diabetic renal disease
- DN
- diabetic nephropathy
- MN
- membraneous nephropathy
- AIN
- acute interstitial nephritis
- IgAN
- IgA nephropathy
- FSGS
- focal segmental glomerulosclerosis